Bing505z
04-21-2017, 08:44 AM
Specks describes unmet needs in management of granulomatosis with polyangiitis, microscopic polyangiitis
April 6, 2017
CLEVELAND — Ulrich Specks, MD, professor of medicine at the Mayo Clinic College of Medicine, described unmet needs in the management of granulomatosis with polyangiitis and microscopic polyangiitis at the Primary Vasculitides Pre-symposium of the Biologic Therapies VII Summit.
“Glucocorticoid avoidance is the primary focus of clinical research in [granulomatosis with polyangiitis] GPA and [microscopic polyangiitis] MPA,” Specks said. “Lower-dosing regimens, almost no glucocorticoids, more effective remission maintenance in order to avoid re-exposure need for remission induction therapy [and] better targeted remission regimens are all the focus of research currently.”
http://www.healio.com/rheumatology/vasculitis-and-giant-cell-arteritis/news/online/%7B9ce3a0a0-c969-40df-a347-48fc6ff5dcbb%7D/specks-describes-unmet-needs-in-management-of-granulomatosis-with-polyangiitis-microscopic-polyangiitis
April 6, 2017
CLEVELAND — Ulrich Specks, MD, professor of medicine at the Mayo Clinic College of Medicine, described unmet needs in the management of granulomatosis with polyangiitis and microscopic polyangiitis at the Primary Vasculitides Pre-symposium of the Biologic Therapies VII Summit.
“Glucocorticoid avoidance is the primary focus of clinical research in [granulomatosis with polyangiitis] GPA and [microscopic polyangiitis] MPA,” Specks said. “Lower-dosing regimens, almost no glucocorticoids, more effective remission maintenance in order to avoid re-exposure need for remission induction therapy [and] better targeted remission regimens are all the focus of research currently.”
http://www.healio.com/rheumatology/vasculitis-and-giant-cell-arteritis/news/online/%7B9ce3a0a0-c969-40df-a347-48fc6ff5dcbb%7D/specks-describes-unmet-needs-in-management-of-granulomatosis-with-polyangiitis-microscopic-polyangiitis